Sialyltransferase 7F inhibitors are a class of chemical compounds specifically designed to block the activity of sialyltransferase 7F (ST8SIA7), an enzyme involved in the transfer of sialic acid residues to glycoproteins and glycolipids. Sialyltransferases are essential in the process of sialylation, a post-translational modification where sialic acid is added to the terminal positions of glycan chains. This modification plays a critical role in cellular recognition, communication, and signaling. Sialyltransferase 7F, in particular, catalyzes the transfer of sialic acids to the terminal ends of N-linked or O-linked glycans on proteins and lipids. These modifications are crucial for regulating various biological processes, including cell adhesion, immune responses, and molecular stability. Inhibitors of sialyltransferase 7F are designed to interfere with this enzymatic activity, blocking the attachment of sialic acids to target glycans.
The design and development of sialyltransferase 7F inhibitors require a detailed understanding of the enzyme's catalytic site, where the transfer of sialic acid occurs. Structural biology techniques, such as X-ray crystallography, molecular docking, and computational modeling, are used to identify critical regions within the enzyme responsible for binding both the donor substrate (CMP-sialic acid) and the acceptor glycan. Inhibitors are designed to bind competitively to these active sites, preventing the enzyme from catalyzing the sialylation reaction. These inhibitors are assessed using biochemical assays to measure their binding affinity, specificity, and effectiveness in inhibiting sialyltransferase 7F activity. By studying these inhibitors, researchers can gain insights into the broader role of sialylation in cellular processes and the specific functions of sialyltransferase 7F in regulating glycan structure and function. This research enhances our understanding of how glycosylation affects cell biology and the importance of enzymes like sialyltransferase 7F in the post-translational modification landscape.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY 294002, a PI3K inhibitor, could disrupt the PI3K/AKT signaling pathway, which may be necessary for the transcriptional activation of glycosylation enzymes, potentially leading to a reduction in Sialyltransferase 7F levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin might inhibit mTOR, a crucial kinase for cell growth and protein synthesis, which could result in a global reduction of protein synthesis including that of Sialyltransferase 7F, leading to its decreased expression. | ||||||